Skip to content

New Dimension in Chromatography - Halo® 1.5

LC-MS Separation of Kratom and its Metabolite on HALO® C18, 2 μm

clinical toxicology testing - lc-ms separation of kratom and its metabolite

Bonded Phase: Biphenyl

Market Segment: Clinical/Toxicology

Particle Size: 2 µm

Pore Size: 90 Å

Product Segment: SMALL MOLECULE

Separation Mode: Reversed Phase

USP Number: L1

Download File
Back To Top